Web Search Site Search HCV Patient Assistance Programs (click here for details)   Grant Opportunity from Janssen: (click here for details)   Ryan White Care Act Hepatitis C & B Language (click here for details)   NYS PrEP Announcement from AIDS Institute (click here for details)   Current HIV Articles and News Updates     HIV     CROI: Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 48 Analysis - (02/27/15)   CROI: Treatment with a TLR7 Agonist Induces Transient Viremia in SIV-Infected ART-Suppressed Monkeys - (02/27/15)   CROI: TLR7 Agonist GS-9620 Activates HIV-1 in PBMCs from HIV-Infected Patients on cART - (02/26/15)   CROI: BMS-955176: Antiviral Activity and Safety of a Second-Generation HIV-1 Maturation Inhibitor - (02/27/15)   CROI: Renal and Bone Safety of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate - (02/27/15)   CROI: GILEAD ANNOUNCES SVR12 RATES FROM PHASE 3 STUDY EVALUATING HARVONI® FOR THE TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS CO-INFECTED WITH HIV - (02/27/15)   CROI: Study of Next-Generation Investigational HIV-1 Maturation Inhibitor Shows Positive Results in Preventing Viral Replication via Different Mechanism of Action Than Current Therapies - (02/27/15)   CROI: HIGH SVR REGARDLESS OF TIME TO SUPPRESSION WITH OMBITASVIR/PARITAPREVIR/R & DASABUVIR + RBV - (02/27/15)   CROI: Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF) - (02/27/15)   CROI: Safety of Tenofovir Alafenamide in Renal Impairment - (02/27/15)   CROI: Exposure to antiretrovirals and development of chronic kidney disease - D:A:D Study Group - written by Mark Mascolini - (02/27/15)   CROI: Fat and lean mass changes similar with raltegravir and PIs in ACTG analysis - written by Mark Mascolini - (02/27/15)   CROI: Rosuvastatin halts carotid artery wall thickening in placebo-controlled trial - written by Mark Mascolini - (02/27/15)   CROI: Do gut flora play key role in cardiovascular disease with HIV? - written by Mark Mascolini - (02/27/15)   CROI: Lower CD4 count, higher viral load tied to primary MIs in NA-ACCORD - written by Mark Mascolini - (02/27/15)   CROI: TAF easier on kidney and bone signals than TDF in 48-week trials - written by Mark Mascolini - (02/27/15)   CROI: Earlier ART in primary infection leads to bigger drop in cellular HIV DNA - written by Mark Mascolini - (02/27/15)   More HIV Articles...         News Updates     Merck Announces Collaboration with the Medicines Patent Pool to Expand Access to Pediatric Formulations of Raltegravir in Developing Countries - (02/24/15)   The Centers for Disease Control and Prevention's (CDC) annual HIV Surveillance Report titled Diagnoses of HIV Infection in the United States and Dependent Areas, 2013 - (02/24/15)   More News Updates Articles...     Current Hepatitis C and B Articles     Hepatitis C     Daclatasvir+Sofosbuvir-new studies, VX135, Daclatasvir Phase 3 IFN-free, EMA Compassionate Use, Accelerated EMA Marketing Review Recommendation   New DAA Phase 3 Studies for genotype 1 at EASL - in both Treatment-naives, treatment-experienced; simultaneous publications   AASLD: Summary from AASLD 2014 for Hepatitis C Boston 7-11 November 2014 - Jurgen K. Rockstroh M.D., Professor of Medicine University of Bonn, Germany   CROI: Daclatasvir in Combination With Sofosbuvir for HIV/HCV Coinfection: ALLY-2 Study - (02/27/15)   CROI: Ledipasvir/sofosbuvir for 12 Weeks in Patients Coinfected With HCV and hiv-1: ION-4 - (02/27/15)   CROI: Drug Interactions Between the anti-HCV Regimen Ledipasvir/Sofosbuvir and Ritonavir Boosted Protease Inhibitors plus Emtricitabine/Tenofovir DF - (02/25/15)   CROI: HCV recurrence after SVR 20 times more frequent with HIV/HCV than HCV alone - written by Mark Mascolini - (02/25/15)   Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection - (02/24/15)   Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1 A Randomized Trial - (02/24/15)   Hepatitis C and HIV Co-infection Closing the Gaps - Editorial - (02/24/15)   Results from AbbVie's Study of VIEKIRA PAK™ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) Published Online in JAMA; Sub-analyses to be Presented at the Annual Conference on Retroviruses and Opportunistic Infections (CROI) - (02/24/15)   More Hep C Articles...         Hepatitis B     Curing HBV, New Drugs - (01/22/15)   AASLD: Phase 1a Safety and Pharmacokinetics of NVR 3-778, a Potential First-In-Class HBV Core Inhibitor - (01/16/15)   Targeted In Vivo Delivery of siRNA and an Endosome-Releasing Agent to Hepatocytes - (01/13/15)   Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic Hepatitis B Patients - (01/13/15)   More Hep B Articles...   Check Out Our Special NATAP Features   Link to conference listings 5th International Workshop on HIV & Women, from Adolescence through Menopause Saturday 21 and Sunday 22 February 2015 Renaissance Seattle Hotel 5th International Workshop on HIV & Women, from Adolescence through Menopause February 21-22, 2015 http://www.informedhorizons.com/resistance2015/ http://www.croiconference.org/ http://www.apasl2015.org/ 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20 March 2015 - 21 March 2015 Sao Paulo Brazil http://www.virology-education.com/event/ upcoming/4th-la-viral-hepatitis-workshop-2015/ HIV Americas Congress April 16-18 2015 Hotel Royal Pedregal Mexico City, Mexico http://www.hivamericas.org/ http://www.easl.eu/ https://ilc-congress.eu/ http://www.comtecmed.com/chep/2014/ May 2015 (Not Final) Location is not final The 3rd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep 2014) was held in Berlin, Germany on May 1-3, 2014 DDW - Digestive Disease Week http://www.ddw.org/ 16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 26 - 28 May 2015 in Washington DC, USA http://www.virology-education.com/event/upcoming/ 16th-international-workshop-clinical- pharmacology-hiv-hepatitis-therapy/ 10th Hepatitis C Workshop 2015 http://www.virology-education.com/event/ upcoming/10th-hepc-workshop-2015/ 10th Hepatitis C Workshop 2015 will be organized as a half day program during the 13th European Meeting on HIV & Hepatitis (Barcelona, Spain, 3 - 5 June 2015). http://www.virology-education.com/ event/upcoming/11th-co-infection-workshop-2015// IAS 2013 - International AIDS Society July 19-22 2015 Vancouver http://www.ias2015.org/ http://viral-hep.org/ www.icaac.org/ HIV & Aging: 5 October 2015 - 6 October 2015 Washington, DC (tbc) USA http://www.virology-education.com/event/upcoming/ 6th-hiv-aging-workshop-2015/ http://www.idweekinternational.com/Home. aspx?gclid=Cj0KEQiA0aemBRC8p87zv_ mc5qYBEiQAiEEMQUCURIpSxbdexs 7TQX1lRY3sNd0GP1xGXXci8z2KMv0aAiGG8P8HAQ http://www.eacs-conference2015.com/index.php?article_id=1 2nd International Hepatitis Cure & Eradication Meeting 2015 11 November 2015 - 12 November 2015 http://www.virology-education.com/event/upcoming/2nd-international- hepatitis-cure-eradication-meeting-2015/ http://www.aasld.org/events-professional- development/liver-meeting-2015 Friday, November 13, 2015 to Tuesday, November 17, 2015 Moscone West Convention Center San Francisco, California http://www.hiv-persistence.com/ 22nd Conference on Retroviruses and Opportunistic Infections Seattle Washington Feb 23 - 26, 2015   65th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 7-11 2014   HIV Drug Therapy Glasgow November 2-6, 2014 Glasgow, UK   5th International Workshop on HIV and Aging. October 21-22, 2014 Baltimore   ACG Annual Scientific Meeting Philadelphia, PA, October 20, 2014   16th International Workshop on Co-Morbidities and Adverse Drug Reactions in HIV Oct 6-8, 2014   ID Week Oct 8-12 2014 Philadelphia   AASLD/EASL Special Conference on Hepatitis C New York City, New York September 12 - 13   ICAAC 2014 54th Interscience Conference on Antimicrobial Agents and Chemotherapy September 5-9, 2014 Washington, DC   20th International AIDS Conference July 20-25, 2014 Melbourne, Australia   International Workshop on Antiviral Drug Resistance June 3-7 2014, Berlin, Germany   15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy May 19- 21, 2014, Washington, DC   DDW - Digestive Disease Week 2014 May 4, 2014, Chicago Illinois, United States   EASL - The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver London, United Kingdom April 9-13   (APASL) 24th Conference of the Asian Pacific Association for the Study of the Liver Brisbane, Australia 12-15 March, 2014   21st Conference on Retroviruses and Opportunistic Infections Boston MA March 3 - 6, 2014   6th HIV Persistence during Therapy - Sixth International Workshop Miami, Dec 3-6, 2013   Fourth International Workshop on HIV and Women January 13-14, 2014 Washington DC   HEPDART 2013: Frontiers in Drug Development for Viral Hepatitis December 8-12, 2013 Big Island, Hawaii   64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013   4th International Workshop on HIV and Aging October 30-31, 2013 Baltimore, MD   14th European AIDS Conference Oct 16-19 2013 Brussels, Belgium   ID Week October 2-6, 2013 San Francisco   53rd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 10-13 2013, Denver CO   IAS 2013: 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention June 30 - July 3 2013 Kuala Lumpur, Malaysia   International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies June 4-8, 2013 Toronto, Canada   (APASL) 23rd Conference of the Asian Pacific Association for the Study of the Liver 6-9 June, 2013, Singapore   Digestive Disease Week (DDW) May 18-21, 2013 Orlando, FL   14th International Workshop on Clinical Pharmacology of HIV Therapy April 22-24, 2013 The Netherlands, Amsterdam   EASL 48th Annual Meeting April 24th - 28th 2013 The Netherlands, Amsterdam   CROI: 20th Conference on Retroviruses and Opportunistic Infections Atlanta, GA March 3 - 6, 2013   Third International Workshop on HIV and Women January 14-15, 2013 Toronto 11th International Congress on Drug Therapy in HIV Infection 11-15 November 2012 Glasgow, UK 63rd Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 9-12 2012 3rd International Workshop on HIV and Aging November 5-6, 2012 Baltimore MD IDSA Conference (Infectious Disease Society Association) San Diego, CA Oct 17-21 2012 52nd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 9-12, 2012, San Francisco XIX International AIDS Conference July 22-27, 2012 Washington, DC   14th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV Washington DC, July 19-21 2012   International Workshop on HIV & Hepatitis Virus Drug Resistance 5-9 June 2012, Sitges, Spain   EASL 47th Annual Meeting Barcelona, Spain April 18th - 22nd 2012   13th International Workshop on Clinical Pharmacology of HIV Therapy Barcelona, Spain April 16-18, 2012   CROI: 19th Conference on Retroviruses and Opportunistic Infections Seattle, WA March 5 - 8, 2012   The 22st Conference of the Asian Pacific Association for the Study of the Liver APASL Feb 16-19, 2012 Taipei, Taiwan   2nd International Workshop on HIV & Women January 9-10, 2012 Bethesda, Maryland   HepDART 2011 Kauai, HI USA December 4, 2011 - December 8, 2011   62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9   Second International Workshop on HIV and Aging Baltimore, MD October 27-28, 2011   EACS - 14th European AIDS Conference European AIDS Conference Oct 12-15 2011 Belgrade, Serbiay   51th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago, IL September 17-20, 2011   6th IAS Conference on HIV Pathogenesis Treatment and Prevention July 17-20, 2011, Rome   13th Intl Workshop on Adverse Reactions & Comorbidities in HIV July 2011-Rome, Italy   View More Conference Reports...   Coming of AGE. A guide to ageing well with HIV - 06/15/11 La informacion Que Necesitas Sobre el VIH - 06/15/10 New Goals and New Drugs for People With Heavy Anti-HIV Drug Experience - 06/05/07 Do you have HIV/HCV Coinfection? - 11/28/06 HIV 101 : The Basics - 11/28/06 VIH 101 : Lo Basico - in Spanish - 11/28/06 HIV 102 : Care and Treatment of HIV - 11/28/06 VIH 102 : Cuidado Y Tratamiento del VIH - in Spanish - 11/28/06 Hepatitis C and Hepatitis C Co-Infection Handbook PDF Version V 11/08/05 Download More NATAP Publications... Support provided by: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Roche, Schering-Plough, Tibotec, Vertex   Patient Assistance Programs for HCV Therapy from the Drug Manufacturers: Pegylated Interferon and ribavirin If you cannot get reimbursement or coverage for pegylated interferon and ribavirin the manufacturers of pegylated interferon have reimbursement programs which supply free drugs if you qualify. These programs will first help you try to identify sources for reimbursement.   Schering makes Peg-Intron and ribavirin (Rebetol): Call 1-800-521-7157. Roche makes Pegasys and ribavirin (Copegus): 1-800-387-1258.   New Pegasys Patient Assistance Program   has generous provisions for patients who want to start HCV therapy with Pegasys and are uninsured. Since Roche & Genentech merged the Genentech Access Solutions P rogram took over this program starting Sept 1 2010 and as I say it is a generous transparent program.   http://www.pegasysaccesssolutions.com   866 422-2377